Avoro Capital Advisors LLC reports

Company location: New York, NY
Fiscal year end: 31 December

Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

Filter by type:
SC13D
SC13G

SEC filing history

Showing 1-25 of 140 matching filings.

Per page

25

Current page

1

SC 13G

TAYSHA GENE THERAPIES, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

TOURMALINE BIO, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

AVIDITY BIOSCIENCES, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

ARROWHEAD PHARMACEUTICALS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

OCULAR THERAPEUTIX, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SOLENO THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

VERA THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SPYRE THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MARINUS PHARMACEUTICALS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

STRUCTURE THERAPEUTICS INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VERRICA PHARMACEUTICALS INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ASCENDIS PHARMA A/S

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KYMERA THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SPYRE THERAPEUTICS INC.

Filing date: 23 Apr 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KRYSTAL BIOTECH, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

APELLIS PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MADRIGAL PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MERSANA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PMV PHARMACEUTICALS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ASCENDIS PHARMA A/S

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KYMERA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MONTE ROSA THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .